News
Fury as Tech CEO Sues Uber After Being Assaulted by Illegal Immigrant Driver — Then Losing His Account
Biotech CEO Bryan Kobel sues Uber after allegedly being brutally assaulted by an undocumented Uber driver who denied his service dog, leaving him with serious injuries and prompting scrutiny of Uber's driver vetting.
Vaxxas has landed $90 million in debt and equity funding to develop technology that could replace the flu jab and other ...
Biotech-startup CEOs are taking more nuanced approaches to going public amid a downturn. Insider talked to the leaders of five privately held biotechs for their views on IPOs in 2023.
Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback